Nichol Ochsner | Vice President of Investor Relations |
Travis Mickle | President and Chief Executive Officer |
LaDuane Clifton | Chief Financial Officer |
Sumant Kulkarni | Canaccord |
Jonathan Aschoff | Roth Capital Partners |
Good afternoon, and welcome to the KemPharm Third Quarter 2022 Corporate and Financial Results Conference Call. Currently, all callers have been placed in a listen-only mode and following management’s prepared remarks, the call will be opened up for questions. [Operator Instructions] Please be advised that today’s call is being recorded. I will now turn the call over to Nichol Ochsner, KemPharm’s Vice President, Investor Relations and Corporate Communications. Thank you.